2024: PCDS Smart London
For UK healthcare professionals only.
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. Novo Nordisk has provided sponsorship to the PCDS towards the running of this conference, in support of continued medical education, and has no influence over any of the sessions. Novo Nordisk has been granted stand space and will be present at the conference.
Join us for a look at the intricate landscape of diabetes, obesity and other common long-term conditions, led by the Primary Care Diabetes Society in conjunction with experts from secondary care. A series of presentations will explore the latest guidelines, evidence, and practical strategies for navigating the intersection between diabetes and other long-term conditions – from cardiovascular disease to cancer. The intrinsic links between diabetes and obesity will also be explored, with a look at what weight management means in the context of multiple long-term conditions.
Gain valuable insights on how patient pathways between primary and secondary care could be optimised, and what practical steps can be taken to promote collaboration across the entire multidisciplinary team. The day concludes with a panel discussion on how to best prioritise care when faced with multiple long-term conditions needing urgent management.
Claim 5 CPD points for the one-day conference
Guidance and advice for primary care from both primary and secondary care experts
Inspiration and new contacts with various opportunities to network alongside your peers
Friday 12 July – 09:00 – 16:20
Registration and refreshments
Type 2 Diabetes in 2024: How can we support people with the use of incretins?
This is a promotional symposium developed and funded by Lilly for GB healthcare professionals. Lilly products will be discussed. Lilly has provided a sponsorship towards this Conference, however have had no input, control or influence over the agenda, speaker selections, presentations or collateral content, except for this symposium session. The speakers for this sponsored symposium have been selected, briefed, and paid an honorarium by Lilly.
PP-TR-GB-0514 June 2024
Dr Yassir Javaid and Dr Victor OguntoluWelcome and NHSE overview
Clare HamblingDiabetes and Obesity
Pam Brown and Matthew CapehornPrimary prevention and MACE outcomes in T2D – A review of the evidence
This is a promotional symposium developed and funded by A. Menarini Farmaceutica Internazionale SRL. Menarini has provided sponsorship towards this conference, however they have not had input, control or influence over the agenda, speaker selections, presentations or collateral content, except for this symposium session.
June 2024|PP-ENDO-UK-0432
Professor Stephen BainCoffee & exhibition
Diabetes, obesity and chronic kidney disease
Waqas Tahir and Andrew FrankelIs this the final piece of the jigsaw? Improving outcomes for adult patients with T2D, HF and CKD
This promotional symposium session has been developed and funded by the Boehringer Ingelheim & Lilly Alliance (Alliance) for UK HCPs only. Alliance products will be discussed at this meeting. The Alliance has provided funding towards the PCDS SMART Conference 2024; however, it has had no input into the agenda, speaker selection, presentations or collateral content, except for this promotional symposium session, which the Alliance is fully responsible for.
PC-GB-110225 | June 2024
Professor Ahmet Fuat and Nadia MalikLunch and exhibition
Diabetes, obesity and cardiovascular disease
Naresh Kanumilli and Ameet BakhaiTick Tock slow the eGFR clock: Managing kidney risk in people with T2D
This is a promotional symposium sponsored and organised by AstraZeneca and is intended for GB HCPs only.
AstraZeneca has provided a sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.
Arshna SanghrajkaCoffee and exhibition
Diabetes, obesity and cancer
Hannah Beba and Safwaan Adam Panel session: Prioritising care in multi-morbidity
Chair: Clare Hambling, Panel: Hannah Beba, Pam Brown, Naresh Kanumilli and Waqas TahirClosing remarks & farewell
Address: ILEC, London 47 Lillie Rd, London SW6 1UD
Directions: The ILEC conference centre is based in West Brompton. It is a 7 minute walk from West Brompton Station to the venue. It has excellent transport links into Central London.
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. Novo Nordisk has provided sponsorship to the PCDS towards the running of this conference, in support of continued medical education, and has no influence over any of the sessions. Novo Nordisk has been granted stand space and will be present at the conference.
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
